Allspring Global Investments’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,516
Closed -$78.9K 2472
2024
Q1
$78.9K Buy
8,516
+7,316
+610% +$85.8K ﹤0.01% 1885
2023
Q4
$15.3K Sell
1,200
-256
-18% -$2.67K ﹤0.01% 1990
2023
Q3
$15K Sell
1,456
-2,795
-66% -$32.4K ﹤0.01% 2560
2023
Q2
$55.7K Buy
4,251
+3,062
+258% +$37.5K ﹤0.01% 2262
2023
Q1
$13.3K Buy
+1,189
New +$11.7K ﹤0.01% 2564
2022
Q3
Sell
-317,499
Closed -$4.67M 2918
2022
Q2
$4.67M Sell
317,499
-83,106
-21% -$1.71M 0.01% 1001
2022
Q1
$9.94M Buy
400,605
+6,996
+2% +$181K 0.01% 883
2021
Q4
$12.6M Buy
+393,609
New +$14.4M 0.01% 851

Other funds holding LUNG

Allspring Global Investments's LUNG Position: Q2 2024 in Review

Allspring Global Investments sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 8,516 shares — an estimated $78.9K sold.

Allspring Global Investments first reported a position in LUNG in Q4 2021 and held it in 8 quarters. The position peaked at $12.6M in Q4 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Allspring Global Investments reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 8,516 Pulmonx shares in Q2 2024, an estimated $78.9K.
  • Allspring Global Investments first reported a position in Pulmonx in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Pulmonx position peaked at $12.6M in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.